{"id":46968,"date":"2022-08-04T23:01:58","date_gmt":"2022-08-04T21:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/"},"modified":"2022-08-04T23:01:58","modified_gmt":"2022-08-04T21:01:58","slug":"geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/","title":{"rendered":"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022"},"content":{"rendered":"
\n

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2022 financial results after the market closes on Thursday, August 11, 2022 via press release, which will be available on the Company\u2019s website at www.geron.com\/investors<\/a>. Geron will host a conference call to discuss the financial results as well as key upcoming expected milestones at 4:30 p.m. ET the same day.\n<\/p>\n

<\/a><\/p>\n

\nA live webcast of the conference call and related presentation will be available on the Company\u2019s website at www.geron.com\/investors\/events<\/a>. An archive of the webcast will be available on the Company\u2019s website for 30 days.\n<\/p>\n

\nParticipants may access the webcast by registering online using the following link, https:\/\/conferencingportals.com\/event\/SmvlMvWL<\/a>. Participants that are unable to register online can access the conference call via telephone by dialing domestically +1 (888) 330-2434 or internationally +1 (240) 789-2725. The conference ID is 67335.\n<\/p>\n

\nAbout Geron<\/b>\n<\/p>\n

\nGeron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAron Feingold
\n
Investor and Media Relations
\n
investor@geron.com<\/a>
media@geron.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2022 financial results after the market closes on Thursday, August 11, 2022 via press release, which will be available on the Company\u2019s website at www.geron.com\/investors. Geron will host a conference call to discuss the financial results as well as … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46968","6":"format-standard","7":"category-industry"},"yoast_head":"\nGeron to Announce Second Quarter 2022 Financial Results on August 11, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2022 financial results after the market closes on Thursday, August 11, 2022 via press release, which will be available on the Company\u2019s website at www.geron.com\/investors. Geron will host a conference call to discuss the financial results as well as ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-04T21:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220804005001\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022\",\"datePublished\":\"2022-08-04T21:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/\"},\"wordCount\":218,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005001\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/\",\"name\":\"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005001\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\",\"datePublished\":\"2022-08-04T21:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005001\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005001\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/","og_locale":"en_US","og_type":"article","og_title":"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022 - Pharma Trend","og_description":"FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2022 financial results after the market closes on Thursday, August 11, 2022 via press release, which will be available on the Company\u2019s website at www.geron.com\/investors. Geron will host a conference call to discuss the financial results as well as ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-04T21:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220804005001\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022","datePublished":"2022-08-04T21:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/"},"wordCount":218,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005001\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/","url":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/","name":"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005001\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","datePublished":"2022-08-04T21:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220804005001\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220804005001\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/geron-to-announce-second-quarter-2022-financial-results-on-august-11-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46968"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46968\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}